COVID-19 pandemic and cardiovascular disease: where do we stand?

Dimitrios G Chatzis1, Kalliopi T Magounaki2, Ioannis N Pantazopoulos2,3

  • 1Medical School, European University of Cyprus, Nicosia, Cyprus - dimitrioschatzis@yahoo.com.

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, impacting the cardiovascular system. This review details cardiac manifestations like myocarditis and arrhythmias linked to SARS-CoV-2 infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to significant global mortality.
  • While primarily a respiratory illness, SARS-CoV-2 also affects the cardiovascular system.
  • Pre-existing cardiovascular disease is a major risk factor for severe COVID-19 outcomes.

Purpose of the Study:

  • To review current literature on cardiovascular manifestations associated with SARS-CoV-2 infection.
  • To highlight the link between COVID-19 and various cardiac clinical presentations.
  • To underscore the importance of understanding the cardiovascular impact of SARS-CoV-2.

Main Methods:

  • Literature review of recent studies on SARS-CoV-2 and cardiovascular effects.
  • Synthesis of findings on clinical manifestations, comorbidities, and outcomes.
  • Analysis of diagnostic and therapeutic approaches.

Main Results:

  • SARS-CoV-2 infection is associated with diverse cardiovascular complications.
  • Manifestations include acute coronary syndromes, myocarditis, heart failure, arrhythmias, and pulmonary embolism.
  • Individuals with cardiovascular disease face increased mortality risk from COVID-19.

Conclusions:

  • SARS-CoV-2 poses a significant threat to the cardiovascular system.
  • Further research is crucial to fully understand the complex interplay between SARS-CoV-2 and cardiac health.
  • Ongoing research continuously enhances knowledge on diagnosis, treatment, and prevention strategies.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
270
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
778
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
278
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
287
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
239